About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Analysis of Circulating Exosomes in Melanoma Patients

NCT05744076·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Centre Hospitalier Universitaire de Besancon

With

Centre Georges Francois Leclerc

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Melanoma patients admitted in Besançon University Hospital
exigible for immunotherapy such as anti PD-L1/PD-1
Age ≥18 years
Affiliation to a social security system,

You may not be if

Minor patients
Patients who have expressed their opposition to the reuse of their data and biological samples

The record

StatusUnknown

PhaseNo phase

Taking part150

StartedMar 2019

UpdatedFeb 24, 2023

Conditions

Where1

CHU de Besançon
Besançon, France

Clareo Health | Analysis of Circulating Exosomes in Melanoma Patients